Active Pharmaceutical Ingredients (APIs)

  • Letrozole*

    • API Product   :   

      Letrozole*

    • CEP   :   

      -

    • WCC   :   

      ?

    • Therapeutic Use    :   

      Cytostatic Hormone Therapy; Antineoplastics

    • Originator   :   

      Novartis

    • CAS No.    :   

      112809-51-5

    • Trade Name.   :   

      FEMARA

    • Molecular Weight   :   

      285.303 g/mol

    • Molecular Formula   :   

      C17H11N5

    Application

    This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen.

    General Description

    Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor which is used in the treatment of hormonally-responsive breast cancer after surgery.